Board -2019-Mt g-3-Doc 01a




Gavi Alliance Board Meeting
4-5 December 201 9
Hyatt Regency Hotel, Delhi, India
Quorum: 1 4
Declarations of Interest

Declarations
Section 5.5 of the Conflicts of Interest Policy for Governance Bodies states ?Members
involved in decisio n-makin g processes on behalf o f Gavi must take appropriate action to
ensure disclosure of Interests and Conflicts of Inter est, and take the necessary action in
respect thereof.?
Section 6.2 of the Conflicts of Interest Policy for Governance Bodies further states , ?The duty
to disclose [in 6.1 above] is a continuing obligation. This means that Members are obliged to
disclose any Interests and/or Conflict of Interest, whenever the Member comes to know the
relevant matter.?
The following declarations were made b y members of the Progra mme and Policy Committee
on their most recent annual statements:
Board members:
Member Org anisational Interest s

Financial/Personal/Advisor Int /
Others
Ngozi Okonjo -Iweala , Chair None Gavi -appointed special adviser
William Roedy , Vice Chair None
US State Department, Foreign
Aff airs Policy Board (Member)
with no engagement with USAID
Margaret ( Peggy ) Hamburg
Joint Coordinating Group ,
Co alition for Epidemic
Preparedness Initiative (CEPI)
CEPI Board (Observer) ; Sabin -
Aspen Vaccine Sc ience and
Policy Group ; Vaccine advisory
grou p of the Wellcome Trust ;
Scienti fic Advisory Board on
Global H ealth of the Bill & Melinda
Gates Foundation








Hele n Rees









Chair, South African Health
Products Regulatory Authority
(SAHPRA) ; Board Chair, WHO
AFRO Regional Immunization
Technical Advisory Group ;
Chair, WHO International
Health Regulations (IHR)
Committee o n Polio ; Co -Chai r,
WHO SAGE Working Group
on Ebola Vaccines ; Member,
WHO SAGE Working Group
on the Decade of Vaccines
and Global Va ccine Action
Plan ; Member, WHO SAGE
Working Group on HPV
vaccines ; Member, WHO HSV
Vaccine Advi sory Group ;
Chair, WHO STI Vac cine
None

Board -201 9-Mtg -01 1
Minutes




Gavi Alliance Board Meeting
26-27 June 2019
Global Health Campus , Geneva, Switzerland


1. Chair?s Report

1.1 Finding a quorum of members present, the meeting commenced at 08. 53 local
time on 2 6 June 2019 . Dr Ngozi Okonjo -Iweala, Board Chair, chaired the meeting.

1.2 The Chair welcomed new Board members and Alternate Board members, as well
as Rob Moodie, Chair of the Evaluation Advisory Committee, Cyrus Ardalan, Chair
of the International Finance Facility for Immunisati on (IFFIm) and other directors
of the IFFIm Board. She noted that departing members would be recognised for
their service at the dinner that evening.

1.3 The Board met in closed session during the afternoon of 2 5 June to discuss a
number of items including th e CEO?s 201 9 mid -year performance review, vaccine
supply related challenges, some country audit issues, as well as an initial
discussion on what Gavi support to Middle Income Countries (MICs) might look
like in the 2021 -202 5 strategic period.

1.4 Standing dec larations of interest were tabled to the Board (Doc 01a in the Board
pack). The Chair noted that in the context of the items for decision on the agenda,
there were some Board members who would have conflicts of interest and that
these would be raised at the appropriate time and recorded in the applicable
section of the minutes.

1.5 The Board noted its minutes from 28 -29 November 2018 (Doc 01b) which were
approved by no obj ection on 27 February 2019 . The Board also noted decisions
approved by them by no -objection consent since the last meeting (Doc 01c),
namely , appointments to the Board and Board Committees .

1.6 The Chair refer red to the consent agenda (Doc 01d) where 11 recom mendations
were being presented to the Board for consideration . No requests had been
received to place any of the consent agenda items on the main agenda . The
decisions would be presented at the end of the meeting during the Review of
Decisions.

1.7 The Board also noted its action sheet (Doc 01 e) and workplan (Doc 01 f) and the
Chair encouraged Board members to contribute to the forward plan by raising
issues which they may wish to add either with her directly or with the Board
Secretary. She noted that the style of presentation of the workplan is more detailed
and that it extends out to 2025 which should enable the Board to have a longer -
term view of work going forward.

Board -201 9-Mtg -02 1
Minutes




Gavi Alliance Board Meeting
19 July 2019
Teleconference


1. Chair?s Report

1.1 Finding a quorum of members present, the meeting commenced at 15.00 Geneva
time on 19 July 2019. Dr Ngozi Okonjo -Iweala, Board Chair, chaired the meeting.

1.2 The Chair highlighted that this teleconference had been convened as an
extraordinary meeting of the Board as she felt that the Board, as a whole, should
be engaged in the issues that arose with the donor group in recent consultations
relating to the investment case for the Gavi 2021 -202 5 Strategy (Gavi 5.0).

1.3 She noted that while the Gavi Statutes and By -laws are silent on the convening of
a Board meeting by short notice, meaning that it is held within a period of less than
the required 14 days? notice, Article 2.7.4.1 of the By -laws permits that a meeting
of this nature can proceed provided there is no o bjection (protest) raised at the
commencement of this meeting. As no objections were expressed by Board , the
meeting was duly constituted as a formal meeting of the Board of the Gavi Alliance.

1.4 Standing declarations of interest were included with the materials shared with the
Board in advance of this meeting.

------

2. Gavi Strategy 2021 -2025 ? Investment Case Ask

2.1 The Chair recalled that the purpose of this meeting is to have a clear and agreed
view of what is to be presented as the investment case ask at the Yokohama
Replenishment Launch on 30 August 2019 , including an agreed level of strategic
investments funding .

2.2 She highlighted that this constitutes a high -level projection of the investment need
for the next strategic period to deliver on the strategy and that it will require a
number of specific budget approvals for the respective programmes over that
period . She re called that an ?ask? is a notional fundraising target , and not a budget,
and highlighted that the starting point of the replenishment ask is grounded in the
projections of Board -approved programmes and expenditures as laid out in the
financial forecast for 2021 -2025 .

2. 3 Seth Berkley, CEO, presented an overview of the breakdown of the US$ 8.9 bil lion
for estimated future expenditure highlighting that every component of expenditure

1



Board -2019 -Mtg -3-Doc 01d
Report to the Board
4-5 December 2019



Since the June 201 9 Board meeting, two decision s have been circulated to the
Board electronically for approval by no -objection consent in line with Article s
2.7.3. 2 and 2.7.3.4 of the By -Laws.

1) On 30 July 2019 , Board members were invited to consider approval of the 201 8
Annual Financial Report .

No objections were received prior to the end of 1 2 August 201 9 and the following
decision was therefore entered into the record:

?In accordance with article 2.7.3.2 of the By -Laws, on a no -objection basis the Gavi
Alliance Board:

? Approved the Gavi Alliance 201 8 Annual Financial Report?

2) On 1 October 201 9, Board members were invited to consider approval of the
appointment of Board and Board Committee members.

No objections were received prior to the end of 11 October 2019 and the following
decision was therefore entered into the record:

?In accordance with article 2.7.3.4 of the By -Laws, on a no -objection basis, the
Gavi Alliance Board:

a) Appointed the following Board Members:
? Yibing Wu as an Unaffiliated Board Member in the seat formerly held by
Richard Sezibera, effective 1 November 2019 and until 31 October 2022.
? Mah amoud Youssouf Khayal of Chad as Board member representing the
developing country constituency in the seat currently held by Mahamat
Saleh Aziz of Chad, effective immediately and until 31 December 2021.

b) Appointed the following to the Market -Sensitive Decisions Committee
effective immediately:
? Muhammad Pate (Board Member) until 31 Dece mber 2019.

c) Appointed the following to the Governance Committee effective immediately:
? Omar Abdi (Board Member) until 31 December 2019.

SUBJECT: NO -OBJECTION CONSENT DECISIONS
Agenda item: 01d
Category: For information

1



Board -2019 -Mtg -3-Doc 01e
Report to the Board
4-5 December 2019

Section A: Introduction
Five recommendations are being presented to the Board under the Consent
Agenda for consideration. Detailed information on each of the items can be found
in the relevant Committee paper in a dedicated folder on BoardEffect at :
https://gavi.boardeffect.co.uk/workrooms/6459/resources/24636
Section B: Actions requested of the Board
The Gavi Alliance Board is requested to consider the following recommendations
from the Gavi Alliance Governa nce Committee and Programme and Policy
Committee.
Decision One ? Sudan ?s eligibility for Gavi support in 2020
The Gavi Alliance Programme and Policy Committee recommended to the Gavi
Alliance Board that it:
Approve , exceptionally, that the determination of Sudan?s eligibility for 2020 will
be based on the latest GNI data point instead of the average GNI per capita over
the past three years.
Decision Two ? Board Vice Chair appointment
Governance Committee recommenda tion to be shared with the Board after
Governance Committee meeting of 3 December 2019 .
Decision Three ? Board Committee Chair appointments

The Gavi Alliance Governance Committee recommended to the Gavi Alliance
Board that it:

a) Reappoint the following as Chair of the Investment Committee:
? Stephen Zinser until 30 June 2020

b) Reappoint the following as Chair of the Audit and Finance Committee:
? David Sidwell until 31 December 2020

SUBJECT: CONSENT AGENDA REVISED AT 25 NOVEM BER 2019
Agenda item: 01 e
Category: For Decision

1



Board -2019 -Mtg -3-Doc 01e
Report to the Board
4-5 December 2019

Section A: Introduction
Five recommendations are being presented to the Board under the Consent
Agenda for consideration. Detailed information on each of the items can be found
in the relevant Committee paper in a dedicated folder on BoardEffect at :
https://gavi.boardeffect.co.uk/workrooms/6459/resources/24636
Section B: Actions requested of the Board
The Gavi Alliance Board is requested to consider the following recommendatio ns
from the Gavi Alliance Governance Committee and Programme and Policy
Committee.
Decision One ? Sudan ?s eligibility for Gavi support in 2020
The Gavi Alliance Programme and Policy Committee recommended to the Gavi
Alliance Board that it:
Approve , exceptionally, that the determination of Sudan?s eligibility for 2020 will
be based on the latest GNI data point instead of the average GNI per capita over
the past three years.
Decision Two ? Board Vice Chai r appointment
Governance Committee recommendation to be shared with the Board after
Governance Committee meeting of 2 5 November 2019 and/or 3 December 2019 .
Decision Three ? Board Committee Chair appointments
Governance Committee recommendation to be shared with the Board after
Governance Committee meeting of 2 5 November 2019 and/or 3 December 2019.
Decision Four ? Board and Board Committee member appointments
Governance Committee recommendation to be shared with the Board after
Go vernance Committee meeting of 2 5 November 2019 and/or 3 December 2019 .


SUBJECT: CONSENT AGENDA
Agenda item: 01 e
Category: For Decision

Board -2019 -Mtg -3-Doc 01 f




G avi Alliance Board

Action sheet as of 20 November 2019


Request Matter Responsible Action taken



28 -29
Nov 2018
? 6b
Approaches to Fiduciary Risk
Management in Gavi ?s Cash Grants :
? Board to receive a table of the
proportion of funds tha t go through
government and partner systems
over time to clearly see change.



Secretariat
(Bijleveld )



See Agenda Item
4, December
2019 Board
meeting


26-27
June
2019 ? 3
2016 -2020 Strategy : Pro gress,
Challenges and Risks
? Alliance partners to provide input and
rec ommendations on routine
immunisation , campaigns and
outbreak response
? Board to receive information on
proposed way forward to address
issue of HPV vaccin e supply
const raints for Gavi coun tries



UNICEF ( Abdi )/
W HO (Salama)


IFPMA
(Silb ermann )/
WHO ( Salam a)



Presented to
PPC at October
2019 meeting

TBD


26-27
June
2019 ? 6
Committee Chair and IFFIm Board
report s:
? Board to receive f urther information
on IFFIm investments ca ses , a
simplified narrative on how IFFIm
work s an d more analysis on relative
return on investment histo rically



Secretariat
(Saraka -Yao/
Sison)



See IFFIm Chair
report , December
2019 Board
meeting

Classified as Internal #
Gavi Alliance Board Workplan
Gavi Board Paper Type Mar May June No Obj Oct Dec Mar/Apr June No Obj Nov/Dec Mar/Apr June No Obj Nov/Dec Mar/Apr June No Obj Nov/Dec Mar/Apr June No Obj Nov/Dec Mar/Apr June No Obj Nov/Dec
A.Strategy/Performance/RiskCEO's Report CEO's Report Discussion 2016-2020 Strategy 2016-2020 Strategy: Progress, Risks and Challenges Discussion 2021-2025 Strategy Gavi 5.0 Decision Measurement Framework (Targets & Indicators) Gavi 5.0: Operationalisation Decision Decision Decision Funding Policies* Gavi 5.0: Operationalisation Decision Decision Programmatic Approaches TBD TBD Portfolio Management Processes TBD TBD Review of Partner Engagement Model Gavi 5.0: Operationalisation Decision Decision Innovation (including private sector partnerships) TBD TBD Middle Income Countries (MICs) TBD Decision Decision Risk and Asurance Report Risk and Assurance Report Decision Decision Decision Decision Decision Decision Decision B.Vaccines & SustainablityTyphoid TBD Information Information Pneumococcal AMC (Advance Market Commitment) TBD Information C.PolicyGender Policy Review of the Gavi Gender Policy Decision Decision Co-Financing Policy Gavi 5.0: Operationalisation Decision Decision Eligiblity & Transition Policy Gavi 5.0: Operationalisation Decision Decision Fragility, Emergencies, Refugees Policy TBD TBD Supply & Procurement Strategy Review of Gavi's Supply and Procurement Strategy Decision Decision Transparency and Accountability Policy Decision D.Country ProgrammesNigeria TBD Information Information Information Information Information Information Information PNG TBD Information Information Post-Transition Support (e.g. Angola, Timor-Leste) TBD Information HSIS Support Framework Gavi 5.0: Operationalisation Decision Decision CCEOP Gavi 5.0: Operationalisation Decision Decision E.Finance/Audit & Investigations Annual Accounts Annual Financial Report Decision Decision Decision Decision Decision Decision Decision Financial Forecast Financial Update, including forecast Decision Decision Decision Decision Decision Decision Decision Budget Financial Update, including forecast Decision Decision Decision Decision Decision Audit & Investigations Report Audit & Investigations Report Information Information Information Information Information Information Information F.GovernanceBoard Chair Appointment Board Chair Appointment Decision Decision Board Vice Chair Appointment Consent Agenda Decision Decision Decision Decision Committee Chair Appointments Consent Agenda Decision Decision Decision Decision Decision Decision Board and Committee Appointments Consent Agenda Decision Decision Decision Decision Decision Decision IRC Appointments Consent Agenda Decision CEO Appointment Consent Agenda Decision Decision Secretary Appointment Consent Agenda Decision Decision Treasurer Appointment Consent Agenda Decision Amendments to Governance Documents (Statutes, By-Laws, Committee Charters) Consent Agenda Decision IRC Terms of Reference TBD Decision Audit & Investigations Terms of Reference TBD Decision G.ReportingCommittee Chair Reports Committee Chair and IFFIm Board reports Information Information Information Information Information Information Information Information Information Information Information Information Information IFFIm Chair Reports Committee Chair and IFFIm Board reports Information Information Information Information Information Information Information Information Information Information Information Information Information Replenishment TBD Discussion Discussion Discussion HR Report Closed Session Information Information Information Information Information Information Information Annual Report on Implementation of the Gender Policy Annex to Board pack/On BE as additional materials Information Information CEPI Annual Progress Report Annex to Board pack/On BE as additional materials Information Information Information Information Information Information Information Board and Committee minutes Annex to Board pack/On BE as additional materials Information Information Information Information Information Information Information Information Information Information Information Information Information H. Pre-Board Technical Briefing SessionsTBCTBC
*Includes Eligiblity & Transition Policy, Co-Financing Policy, HSIS Support Framework
Last updated - 20 November 2019
Next Board Meetings : 19 March 2020, Teleconference 11 May 2020, Teleconference 24-25 June 2020, Geneva 16-17 December 2020, TBD
2020 2021 2022 2023 2024 2025
Board Meetings/Retreats Gavi 4.0 Gavi 5.0
Board-2019-Mtg-3-Doc 01g

1



Board -2019 -Mtg -3-Doc 02
Report to the Board
4-5 Dec ember 201 9

















SUBJECT: COUNTRY PRESENTATION ? INDIA
Agenda item: 02
No paper

1



Board -2019 -Mtg -3-Doc 03

Report to the Board
4-5 December 201 9


27 November 201 9

Dear Board members ,
I look forward to seeing you all in Delhi next week . Our meeting has a very full
agenda, com ing at a busy time for the Alliance and the global health community .
On the one hand. w e are focus ed on delivering Gavi 4.0 . The latest WHO -
UNICEF Estimates of Immunisation Coverage (WUENIC) show that the Alliance
is on track to achieve , and in some cases exceed , all of our Mission Indicators as
well as our targets for breadth of protection and coverage with a first dose of
measles vaccine. However, pentavalent coverage is off track , despite 2.5 million
more children being reached in 2018 than in 2015 . This is due in part to
exceptional events in one large country in 2018 (which will likely be reversed in
2019 ) as explained further in the paper on 2016 -2020 Strategy: Progress,
Challenges and Risks . W e are simultaneously preparing to implement Gavi 5.0 ,
including rethinking many of the Alliance?s approaches , policies, processes and
engagement model , planning for our upcoming Replenishment in London on
4 June 2020 , and getting ready to celebrate the 20th anniversary of Gavi?s
creation at the World Economic Forum in Davos.
It is also a busy time for the broader community . As discussed further below, w e
are actively engaged in the process to develop the Immunisation Agenda 2030
and are working with other agencies to begin implementing the Global Action
Plan for Healthy Lives and Wellbeing for All (GAP) . Meanwhile, the health world
is facing reversals in efforts to eradicate polio, control measles and bring the
ongoing Ebola outbr eak in DR Congo to an end . We will therefore have a lot to
discuss and reflect on at our meeting.
Key developments in our global landscape
Accelerating progress on primary healthcare and universal health coverage
At this year?s United Nations General Assembly , world leaders met for their first
ever High -Level meeting on Universal Health Coverage (UHC) . This was an
opportunity to take stock of global progress towards UHC four years after the
launch of the Sustainable Development Goals (SDGs) , and to recommit to
Report of the Chief Executive Officer

1



Board -2019 -Mtg -3-Doc 04


Section A: Executive Summary
Context
Gavi?s current m ission for the 2016 -2020 period is to save children?s lives and
protect people?s health by increasing equitable use of vaccines in lower -income
countries . It is guided by four strategic goals: accelerating vaccine coverage and
uptake, strengthening health and imm unisation systems, improving sustainability
of national immunisation programmes and shaping markets. In June 2019, the
Board approved the Gavi 2021 -20 25 (?Gavi 5.0?) strategy, with the vision of ?leaving
no one behind with immunisation?.
Questions this pap er addresses
This report presents a holistic view of Alliance -wide progress, challenges and
potential risks 1 in implementing Gavi?s 2016 -2020 strategy , and a short update on
the ongoing operationalisation of Gavi?s 2021 -2025 strategy (?Gavi 5.0?) .
Conclusions
The Alliance is fully on track on all of its five Mission indicator s. We are also
seeing good progress on a number of key indicators across the four strategic
goals , including breadth of protection, MCV1 (first dose of measles vaccine)
coverage, strengthening supply chains, c ountry fulfilment of co -financing
commitments and reductions in vaccine prices. However, challenges also
persist , such as less than targeted improvement in Penta3 coverage and
difficulties with measuring progress on our equity indicators .
The six Gavi 5.0 operationalisation workstreams are in various stages of
development and generally on track , with the policy workstream discussed in Doc
09 and a separate update on the measurement framework as Annex B to the pack
for this Board meeting .


1 Associated risks refer to the top risks described in more detail in the Risk & Assurance Report
2019 (see Doc 11 ).
SUBJECT : 2016 -2020 STRATEGY: PROGRESS, CHALLENGES AND
RISKS
Agenda item: 04
Category: For Information
Report to the Board
4-5 December 2019

04 ? Annex A

Re port to the Report to the Board
Board -201 9-Mtg -3-Doc 0 4 ? Annex A

Annex A : Updated Alliance KPI dashboard








BOARD & COM M ITTEE ATTENDANCE
GENDER BALANCE
Partners3
1
2
3
4
5
6
7
SFA/PEF ACHIEVEM ENTS
CSO ENGAGEM ENT
PLEDGE CONVERSION
DONOR ENGAGEM ENT IN COUNTRY
END 2018TARGET: N/A EVALUATION ALIGNM ENT
END 2018TARGET: N/A COUNTRY REPORTING
END 2018TARGET: 85%
59%
END 2019TARGET: 50%
END 2019TARGET: 100%
END 2018TARGET: N/A
END 2018TARGET: 95%
Governance4
1
Secretariat & partners1
2
4
5
6
VACCINE INTRODUCTIONS
END 2019TARGET: 56 NEW VACCINE COVERAGE
END 2019TARGET: 90%
END 2019TARGET: 90% HSS PROPOSAL QUALITY
END 2019TARGET: 75% HSS FUND UTILISATION
END 2019TARGET: 75% HSS GRANT TARGETS
END 2018TARGET: 50% 50%
Secretariat
OPERATIONAL DEM AND FORECAST
PROGRAM M E FINANCE FORECAST
SPEED OF CASH GRANT DISBURSEM ENTS
END 2019 TARGET: 9 months AUDITS ON TRACK
END 2019TARGET: 80% RISK M ANAGEM ENT PLAN PROGRESS
END 2019TARGET: 60% OPERATING EFFICIENCY
TARGET: N/A?
END 2018 TARGET: +/-10%
18%
END 2018TARGET: +/-10%
1
2
2016 ?2020 INDICATORS ALLIANCE PROGRESS
4
Gavi BoardUPDATED: 25 October 2019
PARTNER GROUP PEF
PEF
CSO
DONORS
DONORS
COUNTRIES
TCA ACTIVITIES ON TRACK
5 EVALUATIONS
Health system strengtheningTargeted country assistanceStrategic focus areaPartners' engagement frameworkCivil society organisation
HSSTCASFAPEFCSO
END 2019TARGET: 90% 87%
END 2019TARGET: 40%
50%
82%
2018BASELINE: 46
2018BASELINE: 95%
2018BASELINE : 13%
2018BASELINE: 100%
2018BASELINE: 61%
2017BASELINE : 27%
2018BASELINE: 17.5 months
2018BASELINE :80 %
2018BASELINE : 60%
2017BASELINE $283k:
2016BASELINE : -3%
2016BASELINE : -16%
2018BASELINE: 80 %
2018BASELINE : 76%
2017BASELINE : 53%
2017BASELINE : 89%
2017BASELINE : 45%
2017BASELINE : 8
2017BASELINE : 92%
2018BASELINE : 90%
2018BASELINE : 44%
25
ON TRACKMODERATE DELAYS / CHALLENGESSIGNIFICANT DELAYS / CHALLENGES
6
TRACKING TREND ONLY
45%
89%
510
94% 58%
87%
95%
96%
-19%
-10%
10%
278K
NO UPDATE AT THIS REPORTING PERIOD
3M EASLES CAM PAIGN COVERAGE
No update
11.5months
4
5
6
3
2
1
2
No update No update
42%